We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Oxford University Begins Phase 3 COVID-19 Vaccine Trial in Brazil
Oxford University Begins Phase 3 COVID-19 Vaccine Trial in Brazil
The University of Oxford is ready to launch a phase 3 trial in Brazil of AstraZeneca (AZ)’s COVID-19 vaccine candidate, considered by the World Health Organization (WHO) to be the frontrunner in the research race.